Stay in touch
Prime news from our network.
#read
Leipzig physician researches new molecular switch for diseases
Professor Berend Isermann from Leipzig University has received an ERC Advanced Grant worth around 2.5 million euros from the European Research Council. This prestigious grant will enable him and his interdisciplinary team to research the molecular mechanisms of thrombo-inflammation over the next five years. Thromboinflammation is a pathological process that occurs in many serious diseases such as myocardial infarction, kidney disease and COVID-19 and is currently difficult to treat.
11/09/2024
The research centres on a newly discovered molecular switch that controls both inflammation and coagulation processes. This switch could be a decisive factor in the control of these diseases. The team plans to study the regulation of this switch, investigate its importance in different disease models and develop new therapeutic approaches to target the switch. The results could lead to important advances in the treatment of diseases such as heart disease, cancer and autoimmune diseases. Professor Isermann sees this as a potential milestone in medical research.
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.